Testing safety of an embolectomy catheter used during clot surgery
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study follows patients who are having surgery to remove a blood clot in an artery or vein and where a specific clot-removal catheter (the LeMaitre TufTex Single Lumen) is used. It aims to confirm how well the device works and monitor safety outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your doctor must be planning surgery to remove an artery or vein clot, using this specific catheter.
- You must be diagnosed with an embolus (clot that traveled) or a thrombus (clot that formed).
- Thrombolytic (clot-busting) medicine must have failed or cannot be used for you.
- You must be able and willing to sign informed consent for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a specific over-the-wire catheter (TufTex) is safe and works well when doctors remove blood clots (embolus/thrombus) during surgery. You might join if you’re having a planned clot-removal procedure and other clot-dissolving medicines have not worked or can’t be used.
This study tests a special catheter (a thin tube) designed to remove blood clots from large arteries in the brain during a stroke. The goal is to see if it is safe and effective at restoring blood flow.
This study tests a procedure to remove blood clots from the lungs in people with moderate or severe pulmonary embolism. It may help reduce strain on the heart and improve recovery.
This trial tests how safe and effective a clot-removal procedure done through the blood vessels is for people with acute or subacute blocked blood flow in the lower leg. It may help by improving circulation while carefully tracking risks and results.
This trial tests a device that removes blood clots from the lungs in people with a recent pulmonary embolism. It may help improve blood flow and reduce strain on the heart.
This study looks at how well different treatments work for a blood clot in the lung (pulmonary embolism). It includes people who are getting or have already gotten a clot-dissolving medicine or a catheter procedure to remove the clot.
Hear when a new Arterial Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.